FDA approves alopecia drug that restores hair growth in most patients in trial

The FDA on Monday approved a new treatment for alopecia areata, a condition that causes hair loss and affects more than 300,000 people a year in the U.S.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...